Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (C-Term) Peptide
BCAR1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN1541339
Quick Overview for Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) (C-Term) Peptide (ABIN1541339)
Target
BCAR1
(Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- YVHLQGKEEF EKTQKELLEK GSITRQGKSQ LELQQLKQFE RLEQEVSRPI
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
-
Background
-
BCAR1, or CAS, is an Src family kinase substrate involved in various cellular events, including migration, survival, transformation, and invasion.
Alias Symbols: CAS, CAS1, CASS1, CRKAS, FLJ12176, FLJ45059, P130Cas
Protein Size: 660 -
Molecular Weight
- 72 kDa
-
Gene ID
- 9564
-
NCBI Accession
- NM_001170721, NP_001164192
-
UniProt
- B3KWE2
Target
-
You are here:
